Literature DB >> 1632677

Prostaglandin E2 production during hepatic regeneration downregulates Kupffer cell IL-6 production.

J A Goss1, M J Mangino, M W Flye.   

Abstract

The liver possesses the remarkable ability to regenerate to its original size after a 70% partial hepatectomy. There has been little effort to characterize the Kupffer cells' role in this unique mammalian reparative physiologic phenomenon. The capacity of rat Kupffer cells (KC) isolated at specific intervals after partial hepatectomy to produce interleukin-6 (IL-6) and prostaglandin E2 (PGE2) in response to endotoxin was evaluated in standard RPMI-1640 (1200 microM L-arginine) and arginine-depleted RPMI-1640 (10 microM L-arginine) media. Regenerating liver KC 48 to 120 hours after partial hepatectomy responded to endotoxin stimulation with a significantly greater (p less than 0.05) production of IL-6 in standard RPMI-1640. Because Kupffer cells function in an environment where high arginase activity results in negligible L-arginine levels, the 10 microM L-arginine RPMI-1640 was used to simulate the true hepatic microenvironment. Production of IL-6 by regenerating liver KC was further increased (p less than 0.05) by placing these same KC in 10 microM L-arginine RPMI-1640 tissue culture media. During the same period, regenerating liver KC produced significantly (p less than 0.01) more PGE2 than sham-operated KC in both standard and low-arginine media. When the cyclo-oxygenase inhibitor indomethacin (1 x 10(-5) M) was added to cultures, the PGE2 production was inhibited, and IL-6 production was upregulated (p less than 0.05) in arginine-depleted cultures. The authors conclude that during hepatic regeneration KC IL-6 production is elevated but controlled in an autoregulatory fashion by KC PGE2 production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632677      PMCID: PMC1242501     

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  26 in total

1.  New perspectives on liver regeneration.

Authors:  N Fausto
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

2.  Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration.

Authors:  R P Cornell
Journal:  Am J Physiol       Date:  1985-11

3.  Stimulation of DNA synthesis and mitosis of hepatocytes in primary cultures of neonatal rat liver by arachidonic acid and prostaglandins.

Authors:  P G Andreis; J F Whitfield; U Armato
Journal:  Exp Cell Res       Date:  1981-08       Impact factor: 3.905

Review 4.  Prostaglandins as possible triggers for liver regeneration after partial hepatectomy. A review.

Authors:  Y Miura; N Fukui
Journal:  Cell Mol Biol Incl Cyto Enzymol       Date:  1979

5.  Lysosomal enzyme activity in hepatocytes and Kupffer cells from intact and partially hepatectomized rats.

Authors:  D N Mayanskii; V I Scherbakoff; N N Mayanskaya; L E Panin
Journal:  Biochem Exp Biol       Date:  1980

6.  The possible role of reticulo endothelial system in hepatic regeneration.

Authors:  A Namasivayam; N Padmanabhan
Journal:  Indian J Physiol Pharmacol       Date:  1982 Apr-Jun

7.  Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Authors:  K Ikebuchi; G G Wong; S C Clark; J N Ihle; Y Hirai; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Growth-stimulating factor in regenerating canine liver.

Authors:  T E Starzl; A F Jones; J Terblanche; S Usui; K A Porter; G Mazzoni
Journal:  Lancet       Date:  1979-01-20       Impact factor: 79.321

9.  Regeneration of rat liver: transfer of humoral agent by cross circulation.

Authors:  F L Moolten; N L Bucher
Journal:  Science       Date:  1967-10-13       Impact factor: 47.728

10.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

Authors:  Y Takai; G G Wong; S C Clark; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

View more
  6 in total

1.  Modulation of human hepatocyte acute phase protein production in vitro by n-3 and n-6 polyunsaturated fatty acids.

Authors:  S J Wigmore; K C Fearon; J A Ross
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

Review 2.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

3.  Pretreatment with enteral cholestyramine prevents suppression of the cellular immune system after partial hepatectomy.

Authors:  P A Van Leeuwen; M A Boermeester; A P Houdijk; S Meyer; M A Cuesta; R I Wesdorp; M L Rodrick; D W Wilmore
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

4.  Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.

Authors:  Alastair J O'Brien; James N Fullerton; Karen A Massey; Grace Auld; Gavin Sewell; Sarah James; Justine Newson; Effie Karra; Alison Winstanley; William Alazawi; Rita Garcia-Martinez; Joan Cordoba; Anna Nicolaou; Derek W Gilroy
Journal:  Nat Med       Date:  2014-04-13       Impact factor: 53.440

5.  Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.

Authors:  Lianne de Haan; Sarah J van der Lely; Anne-Loes K Warps; Quincy Hofsink; Pim B Olthof; Mark J de Keijzer; Daniël A Lionarons; Lionel Mendes-Dias; Bote G Bruinsma; Korkut Uygun; Hartmut Jaeschke; Geoffrey C Farrell; Narci Teoh; Rowan F van Golen; Tiangang Li; Michal Heger
Journal:  J Clin Transl Res       Date:  2018-02-16

6.  Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway.

Authors:  Siyu Yuan; Can Wei; Guofang Liu; Lijun Zhang; Jiahao Li; Lingling Li; Shiyi Cai; Ling Fang
Journal:  Cell Prolif       Date:  2021-11-22       Impact factor: 6.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.